Epileptic Disorders
MENUComparison of twice- and three times daily tiagabine for the adjunctive treatment of partial seizures in refractory patients with epilepsy: an open label, randomised, parallel-group study Volume 3, numéro 2, June 2001
Illustrations
A. Biraben, M. Beaussart, E. Josien, M. Pestre, J.F. Savet, J.L. Schaff, D. Tourniaire, M. Sevestre, J. Renault-Djouadi
Sanofi-Synthelabo, 1, avenue Pierre-Brossolette, 91385 Chilly-Mazarin Cedex, France.
- Page(s) : 91-100
- Année de parution : 2001
Epilepsy is the most common serious neurological condition of adults and children, occurring in approximately 50 million people worldwide [1]. Amongst the variety of different seizure types that are encountered, partial seizure is the most common [2]. Therapy for epilepsy has been available for many years but in about 30% of patients, drug treatment, often with multiple medications, fails to prevent seizures. There is therefore a continuing [...]